Relay Therapeutics (RLAY) has filed another preliminary prospectus, this time for an IPO of 20M common shares at $18 – 19. Gross proceeds should be ~$370M at the midpoint.
It first filed for a $200M debut on June 25 then followed with another filing on July 9 for an offering of 14.7M shares at $16 – 18 (~$250M at midpoint).
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.